study of the effect of drug treatment (OCP and Methergine) in patients with pregnancy remnants

Phase 2

Recruiting

• Conditions: Placental remnants.; Incomplete spontaneous abortion without complication; O03.4

• Registration Number: IRCT20220430054708N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Age over 18 years
Forgotten abortion under 20 weeks
Hemoglobin above 10
No contraindications to receiving Methergine or OCP
Stability of the patient's vital signs at the beginning of the treatment

Exclusion Criteria

Active liver disease
Cardiovascular disease
HTN infection
Advanced neurological disease
Symptoms of infection
Severe bleeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of infection. Timepoint: At the beginning of the study and one month after the start of the study. Method of measurement: Based on the clinical signs, the fever is mostly equal to 38 degrees Celsius.;Gastrointestinal symptoms. Timepoint: At the beginning of the study and one month after the start of the study. Method of measurement: visual analogue scale.;Cardiovascular complications. Timepoint: At the beginning of the study and one month after the start of the study. Method of measurement: Clinical signs.